LIMD2 is the Signature of Cell Aging-immune/Inflammation in Acute Myocardial Infarction

• Published in: Current medicinal chemistry Vol. 31; no. 17; p. 2400
• Main Authors: Tao, Ping, Chen, Xiaoming, Xu, Lei, Chen, Junteng, Nie, Qinqi, Xu, Mujuan, Feng, Jianyi
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2024
• Subjects: Cellular Senescence; Humans; Inflammation - genetics; Inflammation - metabolism; LIM Domain Proteins - genetics; LIM Domain Proteins - metabolism; MicroRNAs - genetics; MicroRNAs - metabolism; Molecular Docking Simulation; Myocardial Infarction - genetics; Myocardial Infarction - immunology; Myocardial Infarction - metabolism; Myocardial Infarction - pathology; RNA, Messenger - genetics; RNA, Messenger - metabolism; immune; Acute myocardial infarction; ceRNAs; inflammation; cell aging; LIMD2
• ISSN: 1875-533X
• DOI: 10.2174/0109298673274563231031044134

Acute myocardial infarction (AMI) is an age-dependent cardiovascular disease in which cell aging, immunity, and inflammatory factors alter the course; however, cell aging-immune/inflammation signatures in AMI have not been investigated. Based on the GEO database to obtain microRNA (miRNA) sequencing, mRNA sequencing and single-cell sequencing data, and utilizing the Seurat package to identify AMI-associated cellular subpopulations. Subsequently, differentially expressed miRNAs and mRNAs were screened to establish a network of competing endogenous RNAs (ceRNAs). Senescence and immunity scores were calculated by single sample gene set enrichment analysis (ssGSEA), ESTIMATE and CIBERSORT algorithms, and the Hmisc package was used to screen for genes with the highest correlation with senescence and immunity scores. Finally, protein-protein interaction (PPI) and molecular docking analyses were performed to predict potential therapeutic agents for the treatment of AMI. Four cell types (Macrophage, Fibroblast, Endothelial cells, CD8 T cells) were identified in AMI, and CD8 T cells exhibited the lowest cell aging activity. A ceRNA network of miRNAs- mNRA interactions was established based on the overlapping genes in differentially expressed miRNAs (DEmiRNAs) target genes and differentially expressed mRNAs (DEmRNAs). Twenty-four marker genes of CD8 T cells were observed. LIMD2 was identified as cell aging- immune/inflammation-related hub gene in AMI. This study also identified a potential therapeutic network of DB03276-LIMD2-AMI, which showed excellent and stable binding status between DB03276-LIMD2. This study identified LIMD2 as a cell aging-immune/inflammation-related hub gene. The understanding of the pathogenesis and therapeutic mechanisms of AMI was enriched by the ceRNA network and DB03276-LIMD2-LAMI therapeutic network.